PPT-The impact of a limited subsidy on access to antiretroviral therapy (ART) and patient

Barnaby Young Infectious Diseases registrar Communicable Diseases Centre Institute of Infectious Diseases and Epidemiology Tan Tock Seng Hospital Singapore Overview F inancing of public healthcare in Singapore and how HIV funding changed in early 2010. Nan Bernstein Ratner. University of Maryland. nratner@umd.edu. CAPCSD 2016. Let me start with a review. With a small twist…. Principles of Evidence-Based Practice (EBP):. Pick a validated treatment (one with evidence). 2017 Cambridge Non-Profit Coalition Winter Summit. Dr. Antonio M. Oftelie. Leadership for a Networked World. Technology and Entrepreneurship Center at Harvard. Harvard School of Engineering and Applied Sciences. The Change Phase…. Wendy T. Behary, Director. The NJ Institute for Schema Therapy. Past President, . The International Society of Schema Therapy, ISST (2010-2014). Elizabeth Lacy, LCSW. Advanced Certified Schema Therapy Trainer and Supervisor . Program Goals. Defining Multiple Myeloma. Case 1. Diagnostic Criteria. Multiple Myeloma Requiring Therapy. Cytogenetic Risk Features. Case 1 (cont). Newly Diagnosed Multiple Myeloma. NCCN. ®. . Therapy for Transplant-Eligible Patients. Opportunities, pitfalls & case studies. Delivering Outcomes via Impact Bonds: Overview. THE CASE FOR OUTCOMES-BASED APPROACHES IN DEVELOPMENT FINANCE. 3. By strengthening the link between funding and impact, outcomes-based approaches improve accountability and enable better development outcomes. . Simi Padival, MD. November 3, 2016. Objectives. Learn about the importance of assessing adherence to antiretroviral therapy (ART). Learn about the components of assessing for ART adherence. Discuss frequency of monitoring while on ART. Module 10:. Pharmacovigilance. Background – definitions. Timeline of pharmacovigilance for a drug from development (pre-market) to post-marketing use. Burden of adverse drug reactions in children. Number of pharmacoepidemiological safety studies in children (Osokogu et al, 2016). Process. How can you balance positive patient outcomes & costs of new, expensive therapies?. Roger Williams Medical Center a CharterCare Health Partner. . . . Presenters: Mark Curtis RPh Pharmacy Clinical Coordinator. ACTIVITY CODE . TD342. Antiretroviral Medications: . What . you need to know. Jason J. Schafer, PharmD, MPH, BCPS, AAHIVP. Associate Professor, Department of Pharmacy Practice. Case Management. George Jagoe . EVP, Access & Product Management, MMV. . . The access team at MMV is heavily focused on the needs of control today. 4. Achieving patient impact means addressing many hurdles to access. to impact changeDrLance Emerson VAHICEO9 November 2018LanceVAHIlanceemersonvahivicgovau2Using patient reported outcomes to impact changeVAHI vision and missionOur visionThe community is better informe . Trikudanathan. , MD, MRCP, . MMSc. Division of Endocrinology, Metabolism and Nutrition. University of Washington Medical Center. Presentation prepared by: . S. . Trikudanathan. Presenter: S. . Trikudanathan. A5173 Study. Intensive . Enfuvirtide. -containing Antiretroviral Therapy . A5173: . Study Design. Source: Gandhi RT, et al. . J . Infect. . Dis. . . 2010;201(2. ):293-6.. Enfuvirtide. +. TDF + (FTC or 3TC) +. coreHEM. : A core outcome set for gene therapy in hemophilia. Elizabeth Clearfield, MHS | May 8, 2023 . Polling Question. Do you believe a core outcome set adds value to the understanding of patient-important outcomes?.